Institute of Science Tokyo · Graduate School of Medical and Dental Sciences

Research keywordsmonocarboxylate transporters・lactate transport・hepatocellular carcinoma・neuroblastoma cells・hMCT2 inhibition・hMCT9 polymorphisms・hypoxic energy metabolism・transporter-targeted pharmacology

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Monocarboxylate Transporters 1 and 2 Are Responsible for L-Lactate Uptake in Differentiated Human Neuroblastoma SH-SY5Y Cells 2024.04; 47 (4): 764-770. ( DOI )2024
• Atorvastatin Exerts More Selective Inhibitory Effects on hMCT2 than on hMCT1 and hMCT4. 2023.07; 43 (7): 3015-3022. ( PubMed , DOI )2023
• Monocarboxylate transporter 4 involves in energy metabolism and drug sensitivity in hypoxia. 2023.01; 13 (1): 1501. ( PubMed , DOI )2023
• Molecular characteristic analysis of single-nucleotide polymorphisms in SLC16A9/hMCT9. 2023.12; 334 122205. ( PubMed , DOI )2023

• Official profile